AC
EW icon

Alexandria Capital’s Edwards Lifesciences EW Stock Holding History

Alexandria Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$404K Buy
3,568
+280
+9% +$32K 0.04% 195
2021
Q2 		$341K Hold
3,288
– – 0.03% 211
2021
Q1 		$275K Hold
3,288
– – 0.03% 229
2020
Q4 		$300K Sell
3,288
-15
-0.5% -$1.24K 0.03% 213
2020
Q3 		$264K Hold
3,303
– – 0.03% 215
2020
Q2 		$228K Hold
3,303
– – 0.03% 220
2020
Q1 		$208K Buy
3,303
+15
+0.5% +$1.08K 0.03% 212
2019
Q4 		$256K Hold
3,288
– – 0.03% 224
2019
Q3 		$241K Sell
3,288
-96
-3% -$6.74K 0.04% 219
2019
Q2 		$208K Buy
3,384
+96
+3% +$5.8K 0.03% 250
2019
Q1 		$210K Buy
+3,288
New +$188K 0.03% 247
2018
Q4 		– Sell
-3,477
Closed -$202K – 255
2018
Q3 		$202K Buy
+3,477
New +$170K 0.03% 226
2017
Q4 		– Sell
-3,498
Closed -$127K – 332
2017
Q3 		$127K Buy
3,498
+60
+2% +$2.29K 0.03% 163
2017
Q2 		$136K Buy
3,438
+57
+2% +$2.08K 0.03% 158
2017
Q1 		$106K Buy
3,381
+3
+0.1% +$94 0.03% 174
2016
Q4 		$106K Buy
3,378
+90
+3% +$2.92K 0.03% 168
2016
Q3 		$132K Sell
3,288
-1,644
-33% -$61.9K 0.02% 171
2016
Q2 		$164K Buy
4,932
+1,644
+50% +$56.2K 0.03% 152
2016
Q1 		$97K Buy
3,288
+1,644
+100% +$45.4K 0.02% 191
2015
Q4 		$43K Buy
+1,644
New +$42.7K 0.01% 273
2015
Q2 		– Sell
-720
Closed -$17K – 616
2015
Q1 		$17K Buy
+720
New +$16.2K 0.01% 327
2014
Q2 		– Sell
-720
Closed -$9K – 591
2014
Q1 		$9K Hold
720
– – ﹤0.01% 368
2013
Q4 		$8K Hold
720
– – ﹤0.01% 385
2013
Q3 		$8K Hold
720
– – ﹤0.01% 387
2013
Q2 		$8K Buy
+720
New +$8.52K ﹤0.01% 404

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alexandria Capital's EW Position: Q3 2021 in Review

Alexandria Capital increased its Edwards Lifesciences (EW) stake by 8.5% in Q3 2021, buying an estimated $32K and bringing the position to 3,568 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #195.

Alexandria Capital first reported a position in EW in Q2 2013 and has held it in 25 quarters since. 1,228 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Alexandria Capital held 3,568 shares of Edwards Lifesciences worth $404K as of Q3 2021.
  • Alexandria Capital bought 280 Edwards Lifesciences shares in Q3 2021, an estimated $32K.
  • Edwards Lifesciences made up 0.04% of Alexandria Capital's portfolio in Q3 2021, its #195 holding.
  • Alexandria Capital first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 25 quarters since.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.